# Iclusig

NDC: 63020-533
Generic name: ponatinib hydrochloride
Labeler / Manufacturer: Takeda Pharmaceuticals America, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: TABLET, FILM COATED
Routes: ORAL
Marketing started: 20150422

FDA application: NDA203469

## Active ingredients

- PONATINIB HYDROCHLORIDE: 30 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"63020-533"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=63020-533
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=16d804b6-4957-43ee-b18c-3b36ec37c5ac